140 related articles for article (PubMed ID: 29569698)
21. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP
Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575
[TBL] [Abstract][Full Text] [Related]
22. Association of SOX2, OCT4 and WNT5A Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Vijayakumar G; Narwal A; Kamboj M; Sen R
Head Neck Pathol; 2020 Sep; 14(3):749-757. PubMed ID: 31902091
[TBL] [Abstract][Full Text] [Related]
23. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
Kaufhold S; Garbán H; Bonavida B
J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
[TBL] [Abstract][Full Text] [Related]
24. Low expression of miR-449 in gynecologic clear cell carcinoma.
Jang SG; Yoo CW; Park SY; Kang S; Kim HK
Int J Gynecol Cancer; 2014 Nov; 24(9):1558-63. PubMed ID: 25238166
[TBL] [Abstract][Full Text] [Related]
25. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
26. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
[TBL] [Abstract][Full Text] [Related]
27. Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.
Wilczynski M; Danielska J; Dzieniecka M; Szymanska B; Wojciechowski M; Malinowski A
PLoS One; 2016; 11(10):e0164687. PubMed ID: 27737015
[TBL] [Abstract][Full Text] [Related]
28. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer.
Li X; Wang J; Xu Z; Ahmad A; Li E; Wang Y; Qin S; Wang Q
Int J Mol Sci; 2012; 13(6):7663-7675. PubMed ID: 22837720
[TBL] [Abstract][Full Text] [Related]
29. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
31. Stromal signatures in endometrioid endometrial carcinomas.
Espinosa I; Catasus L; D' Angelo E; Mozos A; Pedrola N; Bértolo C; Ferrer I; Zannoni GF; West RB; van de Rijn M; Matias-Guiu X; Prat J
Mod Pathol; 2014 Apr; 27(4):631-9. PubMed ID: 24263966
[TBL] [Abstract][Full Text] [Related]
32. Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis.
Chang KH; Albarracin C; Luthra R; Wang L; Zheng W; Malpica A; Deavers MT; Silva EG; Liu J
Int J Gynecol Cancer; 2006; 16(1):178-82. PubMed ID: 16445630
[TBL] [Abstract][Full Text] [Related]
33. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions.
Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M
Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma.
Sato K; Miyamoto M; Takano M; Tsuda H
Virchows Arch; 2021 Nov; 479(5):883-891. PubMed ID: 34331128
[TBL] [Abstract][Full Text] [Related]
35. Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy.
Yang S; Zheng J; Ma Y; Zhu H; Xu T; Dong K; Xiao X
Oncol Rep; 2012 Jul; 28(1):186-92. PubMed ID: 22576801
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.
Kim BW; Cho H; Choi CH; Ylaya K; Chung JY; Kim JH; Hewitt SM
BMC Cancer; 2015 Dec; 15():1015. PubMed ID: 26706028
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.
Wu Y; Liu S; Xin H; Jiang J; Younglai E; Sun S; Wang H
Cancer; 2011 Sep; 117(17):3989-98. PubMed ID: 21365617
[TBL] [Abstract][Full Text] [Related]
39. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
